Review
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.
Cochrane Db Syst Rev. 2022 Jul 13; 7 (7): CD013136CD013136.
Review
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Cochrane Db Syst Rev. 2023 Mar 27; 3 (3): CD009885CD009885.
Review
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
Cochrane Db Syst Rev. 2018 May 9; 5: CD012069.